A new U.S. law will require large parking lots to include solar canopies, turning vast paved areas into clean energy producers. The initiative aims to accelerate renewable power generation, reduce emissions, and create shade and comfort for millions of drivers nationwide.
(c) m
(c) m

Neue US-Gesetzgebung macht Parkplätze zu Solarkraftwerken

ELECTREK

Ein neues Gesetz in den USA verpflichtet große Parkplätze, Solardächer zu installieren. So werden versiegelte Flächen zu Energiequellen, die Emissionen senken, Strom erzeugen und Autofahrern landesweit Schatten und Komfort bieten – ein Gewinn für Mensch und Klima.

Read Full Story

Related Posts

Meistgelesene Artikel

A recent Carbon Brief study shows China’s carbon dioxide emissions have remained unchanged or declined for 18 straight months, thanks in part to a surge in solar (+240 GW) and wind (+61 GW) capacity and a 5% drop in transport emissions.
Chinas CO₂-Emissionen flach oder rückläufig seit 18 Monaten
Scientists at TU Wien have developed a non-toxic “deep-eutectic” solvent that separates blended fabrics — like cotton-polyester mixes — within minutes. Cotton stays intact and polyester is recovered almost fully, offering a near-complete recycling method for textiles that were once nearly impossible to reclaim.
Neuer ungiftiger Lösemittel-Prozess könnte gemischte Textilien recycelbar machen
At COP30 in Belém, Brazil officially created ten new Indigenous territories, including some overlapping Amazon National Park. The move, issued via presidential decree, adds legal protection to lands of groups like the Munduruku and Guarani-Kaiowá during a summit marked by protests.
Brasilien weist 10 neue indigene Gebiete während COP30 aus
Researchers at the University of Cologne have discovered a powerful antibody — 04_A06 — that neutralizes around 98.5 % of over 300 tested HIV strains. In lab experiments the antibody reduced viral load to undetectable levels — a major step toward broad-spectrum therapies for prevention and treatment worldwide.
Durchbruch im Kampf gegen HIV: Antikörper blockiert fast alle Varianten